TRML vs. SLNO
Compare and contrast key facts about Tourmaline Bio Inc. (TRML) and Soleno Therapeutics, Inc. (SLNO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TRML or SLNO.
Key characteristics
| TRML | SLNO | |
|---|---|---|
| YTD Return | -26.13% | 31.48% |
| 1Y Return | 49.11% | 1,016.46% |
| 3Y Return (Ann) | -32.56% | 55.13% |
| Sharpe Ratio | 0.67 | 1.92 |
| Daily Std Dev | 87.39% | 510.10% |
| Max Drawdown | -94.97% | -99.86% |
| Current Drawdown | -76.60% | -91.94% |
Fundamentals
| TRML | SLNO | |
|---|---|---|
| Market Cap | $494.11M | $2.05B |
| EPS | -$1.92 | -$1.83 |
| Total Revenue (TTM) | $2.28M | $3.45M |
| Gross Profit (TTM) | $880.00K | $1.42M |
| EBITDA (TTM) | -$54.49M | -$67.34M |
Correlation
The correlation between TRML and SLNO is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TRML vs. SLNO - Performance Comparison
In the year-to-date period, TRML achieves a -26.13% return, which is significantly lower than SLNO's 31.48% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TRML vs. SLNO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Tourmaline Bio Inc. (TRML) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TRML vs. SLNO - Dividend Comparison
TRML's dividend yield for the trailing twelve months is around 78.17%, while SLNO has not paid dividends to shareholders.
| TTM | 2023 | |
|---|---|---|
TRML Tourmaline Bio Inc. | 78.17% | 57.75% |
SLNO Soleno Therapeutics, Inc. | 0.00% | 0.00% |
Drawdowns
TRML vs. SLNO - Drawdown Comparison
The maximum TRML drawdown since its inception was -94.97%, roughly equal to the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for TRML and SLNO. For additional features, visit the drawdowns tool.
Volatility
TRML vs. SLNO - Volatility Comparison
Tourmaline Bio Inc. (TRML) has a higher volatility of 23.83% compared to Soleno Therapeutics, Inc. (SLNO) at 17.89%. This indicates that TRML's price experiences larger fluctuations and is considered to be riskier than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
TRML vs. SLNO - Financials Comparison
This section allows you to compare key financial metrics between Tourmaline Bio Inc. and Soleno Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities